CHARACTERISTICS OF PIGMENT METABOLISM FOLLOWING THE ADMINISTRATION OF ACELLULAR CRYOPRESERVED BIOLOGICAL AGENTS IN A MODEL OF AUTOIMMUNE HEPATITIS
DOI:
https://doi.org/10.31861/biosystems2024.02.258Keywords:
autoimmune hepatitis, Freund's adjuvant, bilirubin, pigment metabolism, autoimmune diseases, conditioned medium from mesenchymal stem cells, cryoextract of placenta, cryoextract of spleenAbstract
Autoimmune hepatitis (AIH) is an immune-mediated inflammatory disease of the liver caused by a loss of tolerance to the liver's own hepatocyte antigens, leading to autoimmune liver damage. The aim of this study was to characterize the effects of acellular cryopreserved biological agents – conditioned medium from mesenchymal stem cells (MSC-СM), cryoextract of placenta (CEP), and cryoextract of spleen (CES) on the state of pigment metabolism in a rat model of AIH. Assessment of pigment metabolism showed that, in the context of developing AIH, there was a statistically significant (p < 0.001) increase in total bilirubin levels in the blood of rats by 148.9% compared to the values of intact rats, which were 33.4 μmol/L. The increase in total bilirubin in the control group animals was mainly due to an increase in direct bilirubin – its concentration rose significantly (p < 0.001) by 240.0%, reaching 17.0 μmol/L, while the level of indirect bilirubin increased (p < 0.001) by only 98.3% compared to the values of intact rats. In terms of the ability to normalize pigment metabolism in the context of AIH, the studied biological agents can be ranked in the following order (by % decrease in total bilirubin compared to control group values): MSC-СM (52.6%; p < 0.001) > CEP (49.6%; p < 0.001) > CES (40.2%; p < 0.001).
References
1. Fasano, R., Malerba, E., Prete, M., Solimando, A. G., Buonavoglia, A., Silvestris, N., Leone, P., & Racanelli, V. (2022). Impact of antigen presentation mechanisms on immune response in autoimmune hepatitis. Frontiers in Immunology, 12, 814155. https://doi.org/10.3389/fimmu.2021.814155
2. Hladkykh, F. V. (2024). Freund's adjuvant is a classic of vaccine adjuvants and the basis of experimental immunology. The Journal of V.N. Karazin Kharkiv National University. Series Medicine, 32(3(50)). https://doi.org/10.26565/2313-6693-2024-50-9
3. Hladkykh, F. V. (2024). Immune disorders in autoimmune hepatitis: The role of autoantibodies, T-reg cells, and novel therapeutic approaches. Bukovinian Medical Bulletin, 28(3), 76–82. https://doi.org/10.24061/2413-0737.28.3.111.2024.13
4. Hladkykh, F. V., & Liadova, T. I. (2024). Characteristics of the hepatotropic activity of cell-free cryopreserved biological agents in the model of autoimmune hepatitis. The Journal of V.N. Karazin Kharkiv National University. Series Medicine, 32(3(50)). https://doi.org/10.26565/2313-6693-2024-50-01
5. Kohda, H., Sekiya, C., Kanai, M., Yoshida, Y., Uede, T., Kikuchi, K., & Namiki, M. (1990). Flow cytometric and functional analysis of mononuclear cells infiltrating the liver in experimental autoimmune hepatitis. Clinical and Experimental Immunology, 82(3), 473–478. https://doi.org/10.1111/j.1365-2249.1990.tb05474.x
6. Komori, A. (2021). Recent updates on the management of autoimmune hepatitis. Clinical and Molecular Hepatology, 27(1), 58–69. https://doi.org/10.3350/cmh.2020.0189
7. Liberal, R., Mieli-Vergani, G., & Vergani, D. (2016). Autoimmune hepatitis: From mechanisms to therapy. Revista Clinica Espanola, 216(7), 372–383.
8. Lv, T., Li, M., Zeng, N., Zhang, J., Li, S., Chen, S., Zhang, C., Shan, S., Duan, W., Wang, Q., Wu, S., You, H., Ou, X., Ma, H., Zhang, D., Kong, Y., & Jia, J. (2019). Systematic review and meta-analysis on the incidence and prevalence of autoimmune hepatitis in Asian, European, and American populations. Journal of Gastroenterology and Hepatology, 34(10), 1676–1684. https://doi.org/10.1111/jgh.14746
9. Mieli-Vergani, G., Vergani, D., Czaja, A. J., Manns, M. P., Krawitt, E. L., Vierling, J. M., Lohse, A. W., & Montano-Loza, A. J. (2018). Autoimmune hepatitis. Nature Reviews Disease Primers, 4, 18017. https://doi.org/10.1038/nrdp.2018.17
10. Mroskowiak, A., Suleja, A., Stec, M., Kuczmik, W., Migacz, M., & Holecki, M. (2022). Autoimmune hepatitis—Challenging diagnosis. Medicina (Kaunas), 58(7), 896. https://doi.org/10.3390/medicina58070896
11. Poddighe, D., Maulenkul, T., Zhubanova, G., Akhmaldtinova, L., & Dossybayeva, K. (2023). Natural Killer T (NKT) cells in autoimmune hepatitis: Current evidence from basic and clinical research. Cells, 12(24), 2854. https://doi.org/10.3390/cells12242854
12. Terziroli Beretta-Piccoli, B., Mieli-Vergani, G., & Vergani, D. (2022). Autoimmune hepatitis. Cellular & Molecular Immunology, 19(2), 158–176. https://doi.org/10.1038/s41423-021-00768-8
13. Tokuda, K., & Tanimoto, K. (1993). New method of measuring serum bilirubin using vanadic acid. Japanese Journal of Clinical Chemistry, 22(2), 116–122.
14. Vink, K. L., Schuurman, W., & van Gansewinkel, R. (1986). Use of the caffeine reagent in direct spectrophotometry of bilirubin. Clinical Chemistry, 32(7), 1389–1393.
